Pierre Englert

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Inge Christoffer Olsen, F. Lund-Johansen, Mariana H. S. Bernardo, 2023, Critical Care.

Intravascular lymphoma presenting with hypoxaemia, platypnoea and lactic acidosis

M. Vekemans, V. De Wilde, S. Levy, 2021, BMJ Case Reports.